2012-06-28 09:58:46 - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward
GBI Research, the leading business intelligence provider, has released its latest research, "Workforce Reductions in Pharmaceuticals - ". Job losses within the pharmaceutical industry are an on-going reality. In the light of this fact, this new report focuses on managing staff during the redundancy process and managing site closures. It also investigates future outlook for the industry and highlights where the best job opportunities lie.
The report is built using information from primary and secondary research including interviews with experts in the field.
GBI Research analysis shows that all of the biggest pharma companies have been looking hard at the way in which they invest in new product development. Although companies are adopting a number of different ways of tackling the problems
they face, trends that emerge include a focus on emerging markets both in terms of increasing sales and R&D capabilities; an increasing trend towards outsourcing of different activities within drug discovery and development; and increasing reliance on products conceived externally to fuel company pipelines. In order to support innovation externally, companies are spinning out assets whilst retaining an equity stake and board membership, setting up incubators on company premises to support emerging new companies, supporting life science research through the development of innovation funds and venture capital groups to invest in early stage research and developing closer links with academia. Independent bioscience incubators also have a major role to play in supporting the life science community.
Full Report Details at
- www.fastmr.com/prod/405772_workforce_reductions_in_pharmaceutica ..
* Detailed statistics on job losses over the past decade and analysis of the affect of cuts on different job types in different companies.
* Discussion of strategies for improving workforce morale during the redundancy and site closure processes.
* Analysis of site closures across the globe and review of the sale and repurposing of ex-pharma R&D sites.
* Review of the new strategies being adopted by the pharma industry to fuel their future growth and success.
Reasons to buy
* Identify trends in workforce reduction through statistics and in depth discussion of underlying factors leading to the job cuts.
* Develop strategies for managing site closures or redundancies that will help to maintain workforce morale.
* Review the outcomes of site closures in different regions of the globe.
* Understand the ways in which the industry is evolving to meet the new challenges it faces, including greater reliance on external innovation and increased outsourcing.
* Find examples of successful life science incubators that support new companies in their early years and will help fuel the pharma pipelines of the future.
Partial Table of Contents:
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 State of the Pharmaceutical Industry - Job Cuts and Site Closures
2.1 Workforce Reduction
2.1.1 Workforce Reduction by Job Type
2.1.2 Site Closures
2.2 Drivers for Workforce Reduction
2.2.1 Mergers and Acquisitions
2.2.2 Approval Rates and R&D Expenditure
2.2.3 Growth of Generic Medicines
2.2.4 Personalized Medicine and Diagnostics
2.3 Future Outlook
2.3.1 R&D Budgets
3 Managing Staff During the Redundancy Process
3.1 Managing the Transition
3.1.1 Communicating with Employees Across the Organization
3.1.2 Employee Consultations and Redundancy Conditions
3.1.3 Supporting Employees during the Transition
3.2 Productivity Following Restructuring
3.2.1 Costs Associated with Restructuring Companies
4 Managing Site Closures
4.1 Site Redesign: Selling and Repurposing Sites
4.1.1 Selling to CROs: GlaxoSmithKline's Zagreb and Verona Sites
4.1.2 Case Study: Pfizer's Ann Arbor Site
4.1.3 Case Study: AstraZeneca's Lund and Charnwood Sites
4.1.4 Case Study: Pfizer's Sandwich Site
5 Planning for the Future
5.1 Emerging Markets
5.2.1 Outsourcing by Big Pharma
5.2.2 Small and Specialist CROs
5.3 Spin-outs and Licensing
5.4 Hubs, Clusters and Life Science Incubators
5.4.1 Life Science Incubators
5.4.2 Big Pharma Bioscience Incubators
5.4.3 Pharma's Growth Close to Hubs and Clusters
5.4.4 Working with Academia
5.5 Employment Opportunities
6.3.1 Primary Research
6.3.2 Secondary Research
6.4 Contacts Us
List of Tables
1.1 List of Tables
Table 1: Workforce Reductions in Pharmaceuticals, Job Losses from Major Pharma Companies by Year (2007-2010)
Table 2: Workforce Reductions in Pharmaceuticals, Number of Employees in the Largest Pharma Companies (2005-2010)
Table 3: Workforce Reductions in Pharmaceuticals, Employees by Job Function: Novartis (2004 to 2010)
Table 4: Workforce Reductions in Pharmaceuticals, Employees by Job Function: GlaxoSmithKline (2004 to 2010)
Full Table of Contents is available at:
About GBI Research
GBI Research provides industry-leading global business intelligence solutions. Their products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports each year across a wide range of industries. These reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from their expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. View more research from GBI Research at www.fastmr.com/catalog/publishers.aspx?pubid=1016
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.